Cathie Wood’s ARK Invest added to several beaten-down technology and biotech names while trimming positions elsewhere. The investment manager made a notable purchase in gene-editing company CRISPR ...
As climate pressure mounts, new platforms tackle delivery, regulation, trait stacking, and data bottlenecks limiting agricultural genome editing.
One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand treatment to others.
After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...
Researchers at Sanofi report that cas-CLOVER (deactivated Cas9 fused to the C-terminus of Clostridium Clo051) gene editing has the potential to notably enhance recombinant protein production in ...
Researchers are applying CRISPR-Cas9 as a stoichiometric binding tool to improve NGS library normalization. The ...
UK agbiotech Tropic raises $105m to scale gene-edited non-browning and extended shelf-life bananas, and advance TR4-resistant varieties.
Eli Lilly advances CRISPR collaboration with Scribe Therapeutics for neurological and neuromuscular disorders; European ...
Investors have bought into the promise of CRISPR technology for years. The ability to target and edit genes to treat cancer ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsAmy Parison - Senior VP ...
"2025 proved that our technology delivers, not in the distant future, but right now," says Tropic CEO Gilad Gershon.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results